Boyd Watterson Asset Management LLC OH Cuts Position in UnitedHealth Group Incorporated $UNH

Boyd Watterson Asset Management LLC OH decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 19.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 214 shares of the healthcare conglomerate’s stock after selling 53 shares during the quarter. Boyd Watterson Asset Management LLC OH’s holdings in UnitedHealth Group were worth $67,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of UNH. Caitlin John LLC increased its position in shares of UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after buying an additional 111 shares in the last quarter. Triumph Capital Management purchased a new position in shares of UnitedHealth Group in the second quarter valued at $1,324,000. Wealth Effects LLC increased its position in shares of UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after buying an additional 591 shares in the last quarter. Arlington Partners LLC purchased a new position in shares of UnitedHealth Group in the second quarter valued at $2,229,000. Finally, Folger Nolan Fleming Douglas Capital Management Inc. increased its position in shares of UnitedHealth Group by 14.6% in the second quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 28,798 shares of the healthcare conglomerate’s stock valued at $8,984,000 after buying an additional 3,660 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on UNH shares. Morgan Stanley lifted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. KeyCorp lifted their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Piper Sandler dropped their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Oppenheimer dropped their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Finally, JPMorgan Chase & Co. lifted their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Eighteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $385.13.

UnitedHealth Group Stock Up 1.0%

Shares of NYSE:UNH opened at $365.97 on Tuesday. The stock’s 50-day moving average price is $339.58 and its two-hundred day moving average price is $334.29. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The firm has a market cap of $331.45 billion, a price-to-earnings ratio of 15.86, a PEG ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the firm earned $6.80 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.